Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Abbas

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Expert Opinion on Investigational Drugs|June 26, 2012
Vosaroxin : a novel antineoplastic quinoloneJonathan A Abbas, Robert K Stuart
Journal of Community Hospital Internal Medicine Perspectives|October 20, 2022
Primary Mediastinal B-cell Lymphoma Presenting as Chest Pain in a Young Woman and Treated with EPOCH-RChloe Weidenbaum, Akanksha Kushwah, Ariana Geromes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenanceMichiko Shimoda, Faith Mmanywa, Sunil K Joshi, et al.
The Oncologist|August 4, 2022
Venetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the USPankit Vachhani, Evelyn M Flahavan, Tao Xu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|June 26, 2012
Vosaroxin : a novel antineoplastic quinoloneJonathan A Abbas, Robert K Stuart
Journal of Community Hospital Internal Medicine Perspectives|October 20, 2022
Primary Mediastinal B-cell Lymphoma Presenting as Chest Pain in a Young Woman and Treated with EPOCH-RChloe Weidenbaum, Akanksha Kushwah, Ariana Geromes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenanceMichiko Shimoda, Faith Mmanywa, Sunil K Joshi, et al.
The Oncologist|August 4, 2022
Venetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the USPankit Vachhani, Evelyn M Flahavan, Tao Xu, et al.
Pageof 1